These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16516930)

  • 21. Studies on fazadinium bromide (ah 8165): a new non-depolarizing neuromuscular blocking agent.
    Hughes R; Payne JP; Sugai N
    Can Anaesth Soc J; 1976 Jan; 23(1):36-47. PubMed ID: 2378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaches to short-acting neuromuscular blocking agents: nonsymmetrical bis-tetrahydroisoquinolinium mono- and diesters.
    Dhar NC; Maehr RB; Masterson LA; Midgley JM; Stenlake JB; Wastila WB
    J Med Chem; 1996 Jan; 39(2):556-61. PubMed ID: 8558527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of the pharmacology of rocuronium bromide in experimental animals.
    Marshall RJ; Muir AW; Sleigh T; Savage DS
    Eur J Anaesthesiol Suppl; 1994; 9():9-15. PubMed ID: 7925216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the neuromuscular blocking properties and side-effects of the two new isoquinolinium bisquaternary compounds (BW.252C64 and BW.403C65).
    Hughes R
    Br J Anaesth; 1972 Jan; 44(1):27-42. PubMed ID: 4109994
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuromuscular blocking activity of a new series of quaternary N-substituted choline esters.
    Ginsburg S; Kitz RJ; Savarese JJ
    Br J Pharmacol; 1971 Sep; 43(1):107-26. PubMed ID: 4257628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential clinical uses of short-acting nondepolarizing neuromuscular-blocking agents as predicted from animal experiments.
    Savarese JJ; Antonio RP; Ginsburg S
    Anesth Analg; 1975; 54(5):669-78. PubMed ID: 126651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ganglion blocking and vagolytic actions of three short-acting neuromuscular blocking drugs in the cat.
    Marshall IG
    J Pharm Pharmacol; 1973 Jul; 25(7):530-6. PubMed ID: 4147049
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationship between activity and structure in derivatives of clonidine.
    Hoefke W; Kobinger W; Walland A
    Arzneimittelforschung; 1975 May; 25(5):786-93. PubMed ID: 1242325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some actions of chandonium iodide, a new short-acting muscle relaxant, in anaesthetized cats and on isolated muscle preparations.
    Gandiha A; Marshall IG; Paul D; Rodger IW; Scott W; Singh H
    Clin Exp Pharmacol Physiol; 1975; 2(2):159-70. PubMed ID: 237641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simulation of interaction between two non-depolarizing muscle relaxants: generation of an additive or a supra-additive neuromuscular block.
    Nigrovic V; Amann A
    J Pharmacokinet Pharmacodyn; 2004 Apr; 31(2):157-79. PubMed ID: 15379383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Old and new non-depolarizing muscle relaxants: a reassessment on subhuman primates.
    Gyermek L; Wymore M
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):114-29. PubMed ID: 6214226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuromuscular blocking properties of some bistropinium esters.
    HAINING CG; JOHNSTON RG
    Br J Pharmacol Chemother; 1962 Apr; 18(2):275-86. PubMed ID: 13903721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recovery from neuromuscular block after an intubation dose of cisatracurium and rocuronium in lumbar disc surgery.
    Hans P; Welter P; Dewandre PY; Brichant JF; Bonhomme V
    Acta Anaesthesiol Belg; 2004; 55(2):129-33. PubMed ID: 15264506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of 16 beta-pyrrolidinosteroidal derivatives.
    Jindal DP; Piplani P; Fajrak H; Prior C; Marshall IG
    Arzneimittelforschung; 2003; 53(2):73-9. PubMed ID: 12642961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Muscle relaxants. New substances and neuromuscular monitoring].
    Diefenbach C; Nigrovic V; Mellinghoff H; Buzello W
    Anaesthesist; 1997 Jan; 46(1):3-13. PubMed ID: 9082865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.
    Kolhatkar R; Cook CD; Ghorai SK; Deschamps J; Beardsley PM; Reith ME; Dutta AK
    J Med Chem; 2004 Oct; 47(21):5101-13. PubMed ID: 15456254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of 1-azabicyclo[3.3.0]octane derivatives and their effects as piracetam-like nootropics.
    Oka M; Matsumoto Y; Hirooka K; Suzuki T
    Chem Pharm Bull (Tokyo); 2000 Aug; 48(8):1121-4. PubMed ID: 10959574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and structural, conformational, and pharmacological study of some of esters derived from 3-phenethyl-3-azabicyclo[3.2.1]octan-8-beta-ol and the corresponding N-endo-methyl quaternary derivatives.
    Izquierdo ML; Arias MS; Galvez E; Rico B; Ardid I; Sanz J; Fonseca I; Orjales A; Innerarity A
    J Pharm Sci; 1991 Jun; 80(6):554-8. PubMed ID: 1941548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A nondepolarizing muscle relaxant with rapidly developing and short-term action].
    Danilov AF; Zhabko EP
    Eksp Klin Farmakol; 1998; 61(5):18-20. PubMed ID: 9854626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuromuscular blockade: offset anomalies. Are they simply potency-related receptor bonding effects?
    Midgley JM; Stenlake JB
    J Pharm Pharmacol; 1997 Apr; 49(4):416-20. PubMed ID: 9232540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.